Alberta slams federal rollout of COVID-19 vaccine as positivity rate sits at 3.9% In March of last year, Lewis says Entos decided to change direction.
The company had been working on cancer treatments and vaccines but when the COVID-19 pandemic hit, Entos focused on developing a vaccine.They had the people and the know-how.
What they didn’t have was a way to actually make the vaccine.Lewis estimated Entos would need about $50 million to develop the company’s manufacturing capacity.The company has put profits and its own money towards that sum.Officials also asked the federal government for grants and received some money.
Read more on globalnews.ca